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EDITORIAL REVIEW
The biology of renal hypertrophy
Historical aspects
In observing various examples of redundancy in the animal
kingdom, Aristotle (384-322 BC) recognized that there was no
absolute need for two kidneys and that animals born with a
single kidney develop normally [I]. He further recognized that
the degree to which renal mass is reduced determines survival:
"Those which depart only slightly from the natural usually live;
those which depart more than that, do not." Although Hippoc-
rates (or the writings ascribed to him) recommended incision of
the kidneys in cases of abscess or stone [2] there is no mention
of the utility of removal of the kidney to treat such unilateral
afflictions. In fact, the possibility of curing disease by removing
a kidney and allowing the remaining organ to hypertrophy was
not raised by any of the ancients. Even the innovative Galen,
who performed numerous experiments on animals, does not
describe the effect of removal of one kidney. Galen's vivid
imagination led him to state unhesitatingly that "instead of
[creating] one large kidney lying off-center, it was more fitting
[for nature] to establish two small kidneys, one on each side."
[3] He concluded that both kidneys together are required to
remove the serous portion of the blood and presumably felt that
a single organ could not accomplish this function on its own.
Among the numerous cadavers which he dissected, Vesalius
came across instances where only one kidney was to be found
[4]. Similar observations were made by Blasius [50] and
Rhodius [6].
According to Nowinski [7], the first unilateral nephrectomy
was performed in 1869 by the German surgeon Gustav Simon
[8] for treatment of utero-cutaneous fistula. Faced with a patient
requiring surgery and having had no prior experience with the
operation, Simon rapidly worked out the surgical procedure on
dogs and noted the 1.5 fold increase in the size of the remaining
kidney after 20 days. After performing a series of operations on
cadavers he proceeded with the surgery; the patient survived
and was in good health two years later before being lost to
follow-up.
Investigation into the nature and cause of compensatory
hypertrophy proceeded along two lines. First, it was of impor-
tance to determine which structures within the kidney grow in
size and whether this growth is achieved by hypertrophy or
hyperplasia. The second, and more difficult, task was to estab-
lish the functional significance of the hypertrophy and to
determine its initiating stimuli.
The best early anatomical observations were made by Rayer
[9] who observed hypertrophy of one kidney associated with
partial atrophy of the contralateral organ and the existence of
bilateral hypertrophy in diabetes mellitus. Simon erroneously
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considered that growth of the kidney was due to hyperplasia [81.
In 1872, Perl [100] conducted careful investigations on nine
hypertrophied kidneys and correctly concluded that an increase
in the size of the tubular cells was the predominant feature, but
that an increase in cell number also occurred, albeit to a lesser
extent. (Rosenstein [11] had previously concluded that the
increase in the weight of the kidney was predominantly due to
an accumulation of blood lymph and urine.) Confirmation of
Perl's observations was provided by the careful experiments of
Ribbert [12] who compared hypertrophied kidneys of young,
growing dogs and rabbits with normal kidneys from the same
side obtained from their littermates. He demonstrated an in-
crease in weight, volume and cortical mass, and further deter-
mined that glomerular and tubule size were increased by virtue
of hypertrophy and hyperplasia. Lorenz made similar observa-
tions on adult animals but stressed that hypertrophy of the
tubular epithelium was the predominant adaptation [13].
Nothnagel summarized the known facts about hypertrophy in
1886 by stating that the process occurs in both young and adult
animals, involves primarily the cortex, is largely due to
hypertrophy of the convoluted tubules and to a lesser extent the
medullary elements, and includes some cellular hyperplasia,
especially in younger animals [14]. Rollason [15] and Sulkin [16]
sustained these conclusions almost three quarters of a century
later, with little additional information being provided until the
concept of hyperplasia and hypertrophy was stated in modern
biological terms by Johnson in the 1960's [17, 18].
Far more difficult than establishing the structural character-
istics of the hypertrophied kidney was the problem of determin-
ing the basis for the functional adaptation. In 1862 Herman
observed that an increase in urine output from the intact kidney
followed ligation of the contralateral renal artery [19].
Nothnagel [14] considered that this was secondary to retention
of urea. In a brilliant study in which a variety of experimental
situations was examined, Rose-Bradford [20] confirmed that
there was an increase in urine output following 75% nephrec-
tomy in dogs and that this was accompanied by an increase in
the rate of urea excretion if food intake was maintained. Addis
et a! stressed the remaining kidney of uninephrectomized rab-
bits with a urea load and showed that, within three months, it
could eliminate the load as effectively as two normal kidneys
[21].
In his Goulstonian lectures of 1929, Verney [22] described his
work on the function of the experimentally reduced kidney
which he studied by ex-vivo perfusion. In contrast to the
observations of previous workers, he found that although urine
output increased acutely following ligation of one branch of the
renal artery, absolute urea excretion fell. The new finding which
he highlighted was an increase in the rate of chloride excretion
by the reduced kidney. He compared the observed changes
with those induced by a rise in blood pressure and concluded
that the similarity of urine and plasma composition reflected
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partial failure of the remaining renal units after they were called
upon to do more work. With the wisdom of hindsight, it now
seems probable that Verney was observing an osmotic diuress
per remaining nephron secondary to a marked acute rise in the
filtration rates of these units.
Verney considered the polyuric response of the acutely
reduced kidney to reflect mobilization of the "reserve forces of
the kidney" and that the cause for this was a "pressure
diuresis" [23]. He speculated about the similarity between
blood pressure elevation and reduction of renal mass but was
uncertain about whether both were associated with an increase
in "filtration through the Malpighian tufts." Unfortunately,
Verney did not pursue this line of thought and preferred to
ascribe the diuresis of acute reduction in renal mass to a
reduction in the "tone" of the tubular epithelium.
Once it became possible to measure glomerular filtration rate
(GFR) by the clearance of inulin or creatinine, it became
apparent that an elevation in GFR was an invariable feature of
the hypertrophied kidney. In man, 60—90% of the preoperative
two-kidney value was attained within three to four months [24].
Furthermore, an increase in renal blood flow was evident within
three days of unilateral nephrectomy [25] suggesting that hemo-
dynamic events occur in the early stages of hypertrophy.
Since the early increase in urine flow rate following unilateral
nephrectomy was shown to precede a measureable increase in
GFR, Peters [26] suggested that the early increase in tubular
reabsorption of sodium chloride and water, "compensatory
adaptation," should be distinguished from "compensatory
hypertrophy" which is accompanied by an increased GFR.
Unfortunately, this distinction assumes that failure to demon-
strate an increase in GFR within 24 hours [27—29] means that
GFR, indeed, remains constant. In fact, it seems more likely
that the methods used to measure GFR were often too insensi-
tive to detect small increments. More recent studies have
shown that GFR rises within 24 hours of uninephrectomy [30,
31] and is probably a very eariy event which is determined by an
increase in single nephron plasma flow.
Structural considerations
All of the component parts of the nephron are enlarged in
compensatory hypertrophy. Glomerular diameter and volume is
increased in established hypertrophy [32—34], as is the proximal
convoluted tubule, 135—38] the proximal straight tubule [39] and
the collecting tubule [40]. The proximal tubules increase in
length, diameter and volume, the latter indices reflecting an
increase in cell size [32—34, 41—43]. Detailed measurements of
the 1oops of Henle have not been made, but it appears from the
tracings of nephrons studied by Oliver that the loop of Henle
does increase in size following 75% nephrectomy [35]. Oliver
stressed, however, that the proximal tubule grows out of
proportion to the rest of the nephron. This was found both in
the rat and the rabbit [35]. Although it is assumed that all
components of the cell hypertrophy in a symmetrical fashion,
recent studies have shown that the basolateral membrane
hypertrophies out of proportion to the luminal membrane in the
proximal tubule [44].
As described below, protein loading induces hypertrophy in
the normal kidney. The effect of high protein intake is additive
to that of reduction in renal mass, and although the entire
nephron hypertrophies, again, the predominant effect is in the
proximal tubule [35]. The hypertrophy induced by potassium
depletion is clearly different, in that selective growth of distal
nephron segments occurs. This is discussed below.
Hypertrophy versus hyperplasia
A consistent finding in kidneys which have grown in size
following reduction of nephron mass is an increase in cell size.
This is defined as "hypertrophy," and can be accurately
determined by demonstrating an increase in protein/cell,
proteinlDNA or RNA/DNA. In adult animals, 80% of kidney
growth following uninephrectomy can be ascribed to cell
hypertrophy [17, 18] which is predominantly of proximal tubu-
lar origin. In addition to this, there is a small but consistent
increase in the total DNA content of the remaining kidney,
which accounts for 15—30% of the increase in dry weight. This
is due to an increase in cell number and is referred to as
hyperplasia.
In young animals the situation appears to be different. Renal
growth following uninephrectomy in the rat is achieved primar-
ily by cell multiplication, i.e., hyperplasia, as long as the
animals continue to grow [45, 46]. Since new nephron formation
does not occur [47], the increase in total DNA content of the
kidney indicates that the number of cells per nephron increases.
This is an assumption which is based upon the observation that
the amount of DNA per nucleus is constant in the rat [48],
regardless of age. But the possibility that polyploidy may occur
in compensatory renal growth has not been examined rigor-
ously. Nevertheless, hyperplasia has consistently been shown
to be more pronounced in the young than in the adult kidney
[49—53].
In understanding the genesis of these two processes, i.e.,
hypertrophy vs. hyperplasia, two possibilities arise. One is to
assume that each process is under separate control and is
initiated by a specific stimulus. In fact, it has been suggested
that mitosis is stimulated by the cell injury which accompanies
most experimental models of hypertrophy, and that if this can
be prevented the response would be one of pure hypertrophy
[54]. The second possibility is that the two processes are
overlapping events in which a certain percentage of
hypertrophied cells undergo mitosis and cell division while the
majority achieve an increased size without proceeding through
the cell cycle. These alternatives are considered below in the
discussion on the cell cycle.
Compositional changes dnring hypertrophy
RNA and protein metabolism
Following uninephrectomy, the RNA content of the remain-
ing kidney increases, leading to an increase in RNA/DNA ratio
by 12 hours [55, 56]. A substantial increase in protein/cell and
kidney weight occurs between 12 to 48 hours. By 48 hours, in
the mouse and rat kidney, RNA/DNA ratio increase by 20—30%
and remains at this level while renal mass continues to increase
over the next few weeks [55—57], Mitochondrial count/nuclear
count is greatly increased as is the activity of Na—K ATPase
in the outer medulla and cortex [58] suggesting that the in-
creased functional capacity of the enlarged cell is matched by
its ability to synthesize and utilize ATP for transport functions.
The earliest changes in ribosomal RNA content after
uninephrectomy appear to be due to decreased metabolism
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rather than increased synthesis [59]. There is also evidence for
very early (i.e., within 10 minutes) processing of RNA with
heterodisperse sedimentation characteristics which presumably
act as precursors of mRNA [60]. Furthermore a class of rapidly
metabolized mRNA, which is short-lived, has been detected in
mouse kidney and may play a role in determining gene expres-
sion after reduction of nephron mass [61]. It is of interest that
although increased protein content of the kidney can be dem-
onstrated within the first 24 hours, it has not been possible to
show an increase in radiolabelled amino acid incorporation into
proteins [621. Thus, the earliest changes in both RNA and
protein metabolism may be a decrease in metabolism rather
than an increase in synthesis, but these studies require further
elaboration. Unfortunately, no recent studies of transcriptional
and translational events have been performed which utilize
modern techniques of molecular biology, so that the mecha-
nisms underlying the increase in protein content of the
hypertrophied kidney remain uncertain.
Phospholipid metabolism
Phosphatidylcholine is the major phospholipid of cell mem-
branes. It is synthesized from choline, adenosine triphosphate,
cytosine triphosphate and diacylglycerol via the Kennedy path-
way [63]. One of the earliest biochemical changes which occurs
following uninephrectomy is an increase in the incorporation of
choline into phospholipids which is detectable within 5 minutes
in renal cortical slices [64]. It should be pointed out that since
precursor pools were not measured in these studies, the in-
creased tracer incorporation may not be indicative of increased
phospholipid biosynthesis. However, the studies of Hise et al.
have provided direct evidence for stimulated phosphatidylcho-
line synthesis via the Kennedy pathway following uninephrec-
tomy [65]. This enhanced biosynthesis appears to be mediated
by an increase in the activities of choline kinase [66]. This early
increase in phospholipid synthesis, which occurs despite an
experimentally-induced decrease in tubular Na reabsorption,
has been used as an argument against the concept of work-
induced hypertrophy [67]. It should be pointed out, however,
that the experiments upon which this conclusion was based
utilized "sham-left nephrectomy" as a control, a maneuver
which leaves the kidney untouched. It is possible, however,
that the early increase in renal blood flow which occurs follow-
ing nephrectomy could be the primary stimulus to phospholipid
biosynthesis. Unfortunately, the effects of isolated increases in
renal blood flow on phospholipid metabolism, induced by
vasoactive agents, for instance, have not been evaluated.
An increase in phosphatidylcholine biosynthesis has likewise
been reported to precede the renal growth associated with
potassium depletion [67, 68]. Toback has suggested that this is
due to an increase in choline accumulation as a part of a
generalized cellular replacement of cations to maintain
electroneutrality during K loss, to an increase in cholinephos-
photransferase activity and to a decrease in the activity of
phospholipase A, an enzyme which degrades phosphatidylcho-
line [69]. These changes are reversed by K repletion.
Cyclic nucleotide metabolism
The realization that cellular cAMP and cGMP levels may
influence cell growth and proliferation led to investigations
which attempted to link the activities of adenylate and guanyl-
ate cyclase to renal hypertrophy. Schiondorif and Weber
showed that renal growth in rats from seven days to adulthood
is associated with a continuous increase in cAMP/cGMP ratio
[70]. In contrast, immediately following unilateral nephrec-
tomy, cGMP levels rose to 30 percent of initial concentration
within two hours and remained elevated by 150 to 200% for two
weeks. Dicker found an increase in cGMP within 40 minutes
which fell to normal within 90 mins, and was unable to find a
sustained elevation [71]. Yusufi et al obtained similar results
and found that the early increase in cGMP in the rabbit was
localized to the glomerulus [720]. Solomon et al, on the other
hand, were unable to find any consistent changes in cAMP or
cGMP between two hours and seven days after unilateral
nephrectomy [73]. Perhaps because of the inconsistency of the
results this line of research has not been pursued in recent
years.
Mechanisms of induction of hypertrophy
The argument against a link between kidney growth
and renal work
In 1896, Sacerdotti introduced the idea that the enlargement
of the remaining kidney following unilateral nephrectomy was a
response to the need to excrete a greater amount of waste
products and that the kidney must perform "work" in so doing
[74]. Since the concept was simple and apparently logical, it
held sway for a long time. When it became apparent that
protein-loading also caused hypertrophy [75—80] the "work
hypothesis" achieved further credibility since it was believed
that urea, the metabolic end-product of proteins, was excreted
by an active-energy consuming process. Indeed, Walter and
Addis constructed a theoretical scheme to describe "urea
work" and its relation to kidney size [82]. Since urea feeding
also led to renal growth [75, 83] but "salt" feeding did not [75,
81] the idea seemed to be reasonably sound. It soon became
apparent that urea was not transported by an active process and
that the main "work" function of the renal tubules is to reclaim
the filtered sodium and water. The traditional work hypothesis
gave way to a modified version in which renal growth was
viewed as a response to the increased functional demand for
reabsorption of an increased filtered load of solute. In the last
fifteen years, however, a number of studies have appeared
which purport to negate the "work hypothesis." These have
been summarized by Katz et al [67].
The theme of these studies has been to dissociate renal work
from renal growth using two approaches. In the first, specific
experimental models (e.g., ureteroperitoneostomy, hypokale-
mia) are used to show a dissociation between tubular sodium
reabsorption (TNa) and hypertrophy. In the second, the time
courses of growth and increased TNa are compared and found
to be dissociated. Based upon studies such as these it has been
concluded that "compensatory kidney growth is not triggered
by an increase in renal work expended in the reabsorption of
solutes from the glomerular filtrate" [67].
It is well to reexamine the premises upon which this conclu-
sion is based, for the "work hypothesis" may well be valid and
may continue to provide the best explanation for the
hypertrophy which follows reduction in renal mass. One argu-
ment, which has been advanced in opposition to the thesis that
TNa and hypertrophy are linked, is based upon the observation
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that kidney weight increases within 24 hours of unilateral
nephrectomy whereas no increase in TNa was observed [84].
Not only is the measurement of TNa difficult to make with
accuracy (since it is critically dependent upon an accurate
measurement of GER) but, in the study cited, GFR did appear
to increase, albeit insignificantly. Other studies have clearly
shown that GFR does rise shortly after uninephrectomy. Al-
lison et al documented a rise within 2/2 hours [85], whereas
Diezi et al were able to show an increase in superficial SNGFR
even when total GFR was prevented from rising by means of a
suprarenal aortic clamp [861. This being the case, there must be
a significant, early increase in the amount of sodium delivered
to the nephrons of the remaining kidney.
In the acute studies described above, absolute proximal
tubular reabsorption of water (and sodium) remained un-
changed indicating a resetting of glomerulo-tubular balance.
This was associated with an early natriuresis and diuresis. From
these studies it is evident that an early rise in SNGFR precedes
compensatory hypertrophy. It is also clear that over the ensuing
days and weeks, salt and water balance are reestablished
despite the fact that SNGFR remains elevated. This is accom-
panied by an increase in absolute fluid reabsorption by the
proximal tubule, which restores glomerulotubular balance
towards (but not necessarily to) its original setting. Thus the
sequence of events appears to be an early elevation of GFR
followed by an increase in tubular reabsorption of sodium and
water.
The model of uretero-peritoneostomy has been used as a
second argument against the idea that hypertrophy and function
are associated. In this model, SNGFR and tubular reabsorption
of Na increased by 50 to 100% but hypertrophy does not occur
[87, 881. While these observations are important, they suffer
from the obvious problem that delivery of all of the urine into
the circulation may exert an inhibitory effect on renal cell
growth. Since endogenous inhibitors of cell growth are pro-
duced by the renal tubular cells themselves (see below), their
exaggerated accumulation in the extracellular fluid may mediate
this inhibition. The fact that cortical and medullary Na-K
ATPase activity does not rise in this disease model despite an
increase in SNGFR [89] is further suggestive of the action of
inhibitory substances. It is also difficult to understand how
TRna can double over a period of one week without a concom-
itant rise in Nat—K ATPase activity. Unfortunately functional
and enzyme studies have not been performed simultaneously in
this disease model.
The contrary experimental situation has also been created,
i.e., GFR has been prevented from rising following
uninephrectomy by increasing the hydrostatic pressure in the
collecting system [90]. In this case, choline incorporation into
phospholipid in renal cortical slices (taken to be indicative of
early hypertrophy) was increased in the face of a reduction of
sodium reabsorption. It should be pointed out, however, that
renal growth per se was not studied, and, as discussed above, it
is not clear that an early alteration in phospholipid metabolism
is a precursor event which is necessarily specific for
hypertrophy.
Another model which has shown a dissociation between
hypertrophy and function is that of chronic potassium depletion
[68, 69] in which GFR and TRNa are not increased [58]. Once
again it must be stressed that the renal growth observed in this
situation bears little relation to that which occurs in compensa-
tory hypertrophy. In potassium depletion the morphological
characteristics are unique and affect mainly the papilla and
inner medulla [67—69, 91—95]. All cell types become filled with
lysozomes which contain a variety of hydrolases, and an acid
phosphatase [92]. There is hyperplasia of cells in the collecting
tubules, interstitium and ascending thick limbs of Henle's loop.
There, cells form papillary masses which project into the lumen
and demonstrate metabolic changes typical of tumor cells. The
picture is clearly different to that observed in other forms of
hypertrophy.
It is evident from these remarks that all hypertrophy is not
"compensatory" hypertrophy and that the biochemical events
which initiate the different processes may be vastly different.
Evidence that nephron hypertrophy is linked to increased
reabsorptive work
Having raised questions about the validity of the few exam-
ples which have purported to show a dissociation between
hypertrophy and function, it is appropriate to review the vast
body of information which supports such an association. Since
it is the proximal tubular mass which constitutes the bulk of
renal mass and which undergoes the most marked hypertrophy
following reduction of renal mass, it seems appropriate to
search for a consistent correlation between filtration rate and
proximal tubular hypertrophy. Not only should this correlation
exist in situations in which GFR is increased or decreased
uniformly amongst all nephrons, but it should also obtain to
situations of heterogeneous glomerular injury in which an
increased dispersion of SNGFR values occurs within the same
kidney.
Chronic reduction of renal mass either by means of
uninephrectomy or by ablation of 60 to 80% of total renal mass
leaving a small "remnant kidney" leads to a uniform increase in
SNGFR within 1 to 4 weeks (38, 39, 96—106). A similar
adaptation is observed in nonglomerular disease, e.g., pyelone-
phritis [107, 108]. The increase in SNGFR is two— to three—fold
greater than in the normal kidney in both superficial and
juxta-medullary nephrons [104] and is directly proportional to
the extent of reduction of renal mass [106]. Hence there is a
direct correlation between GFR and hypertrophy [108]. Tubular
reabsorption of fluid by the proximal tubule increases in parallel
with the increase in GER [96-98]. The increase in proximal
tubular reabsorption effectively reclaims the bulk of the in-
creased amount of filtrate formed and appears to be governed
by the need to maintain sodium balance, since it is unaltered by
changes in dietary Na intake [96].
The fact that the adaptation in proximal tubular reabsorption
is intrinsic to the tubular epithelial cells and is not solely
dependent upon changes in peritubular or humoral influences
has been demonstrated by examining proximal tubules derived
from remnant kidney in an in vitro situation [31, 38, 39].
Hypertrophied proximal tubules reabsorb fluid at an augmented
rate in vitro. The adaptation is independent of the rate of
perfusion and is not determined by whether the tubules are
exposed to normal or uremic serum [38, 39]. Conversely in a
disease model in which SNGFR was uniformly decreased by
embolizing the glomeruli with microspheres, proximal tubular
reabsorption was decreased without a decrease in the size of the
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tubule [38]. Similar studies performed 24 hours after
uninephrectomy, unilateral ureteral obstruction, or uretero
peritoneostomy (all of which lead to an increase in SNGFR) led
to a consistent increase in proximal tubular fluid reabsorption in
vitro when compared with that observed in tubules obtained
from the normal contralateral kidney studied 24 hours earlier
[311. Taken together, these data provide strong evidence for the
existence of a proximal tubular "memory" [38] which is man-
ifested by a pattern of fluid reabsorption in vitro, which reflects
that which is obtained in vivo, and which correlates closely with
SNGFR.
Perhaps the most rigorous test of the hypothesis that glomer-
ular and proximal tubular structure and function are intimately
related is the kidney of chronic glomerulonephritis in which a
wide disperson of SNGFR values is found [109—113]. In exper-
imentally induced anti-GBM nephritis in rats, mean SNGFR is
decreased as it is in heterologous immune complex nephritis
[110—112]. In the autologous phase of immune complex
nephritis mean SNGFR may be normal or decreased, but in all
of the above models there is marked heterogeneity of SNGFR
within the same kidney. Some nephrons have values for
SNGFR which are as low as half of the normal mean value
whereas in others it is markedly increased. In all cases the ratio
of SNGFR to absolute proximal fluid reabsorption is the same
from nephron to nephron [110-1121. One explanation for this
tight correlation is that the net reabsorptive force acting across
the peritubular capillary network surrounding the proximal
tubule parallels the changes in the hemodynamics of filtration in
the same nephron [112]. Intrinsic changes in epithelial function
presumably also contribute to this phenomenon, although these
have not been examined in vitro in glomerulonephritis.
Not only is proximal tubular reabsorptive function related to
glomerular function but structural parallelism also exists. The
extensive and elegant studies of Oliver [113] showed the close
structural relationship between the size of the glomerulus and
that of the proximal tubule in the nephritic kidney. Simply
stated, small glomeruli are connected to small tubules, normal
glomeruli to normal tubules and large glomeruli to large tubules.
It is this compelling evidence which again leads to the conclu-
sion that hypertrophy of the proximal tubule and the glomerulus
are either simultaneously stimulated by the same exogenous
factor or that tubular hypertrophy is conditioned by glomerular
hyperfiltration. The former possibility while feasible in the
remnant kidney seems most unlikely in the nephritic kidney in
which tubular size varies widely with the degree of glomerular
hypo- or hyperperfusion.
Effect of sustained increases of glomerular filtration rate in
the absence of nephron loss
Apart from the effect of protein loading on GFR and
hypertrophy [114] alluded to above, there are physiological and
pathological circumstances in which a sustained elevation of
GFR occurs. The first of these is chronic volume expansion
secondary to mineralocorticoid excess. This model provides
another indication that proximal tubular hypertrophy is linked
to an elevation in GFR. The studies of Knepper and Burg [115]
revealed that DOCA treatment of rabbits for two weeks re-
sulted in hypertrophy of structure and function in the proximal
tubule only if the animals were maintained on a high salt intake.
DOCA failed to have this effect of its administration was
accompanied by sodium restriction. These results suggest that
the hypertrophy is not due to a direct effect of the mineralocor-
ticoid on proximal tubular cell growth and is presumably related
to the elevation in GFR which accompanies the volume expan-
sion associated with DOCA and salt loading.
Vandewalle and colleagues [116, 117] have investigated the
effects of DOCA on RNA synthesis in the nephron by measur-
ing (3H)—uridine incorporation into different nephron segments.
Heterogeneity of uridine labelling, which was highest in the
cortical ascending limb and in the distal convoluted tubule, was
felt to be due to differences in the basal rates of uridine
incorporation into different segments and to differences in
endogenous nucleotide pools [116]. Whereas the predominant
effect of DOCA on uridine incorporation into nuclei acids was
in the collecting tubules, a 34% and a 90% increase occurred in
the proximal convoluted and straight tubules respectively and
was associated with an increase in the volume of these seg-
ments [117]. Thus, although the specific target site for DOCA is
the distal nephron, the associated volume expansion may lead
to proximal tubular hypertrophy presumably secondary to an
increase in GFR.
Another situation associated with a physiological increase in
GFR is pregnancy. Garland et al examined rats after seven days
of pregnancy and at term, and found that dry kidney weight was
increased at seven days but not at term [118]. Importantly,
however, there was a 20% increase in the length of the proximal
tubules which persisted throughout pregnancy. In mice, the
increase in kidney weight has been shown to be due to
hypertrophy rather than to hyperplasia since RNA levels in-
creased while DNA content remained constant [1191. Unfortu-
nately the increase in dry kidney weight has not been consis-
tently observed, and both Davison and Lindhenner [120] and
Baylis and Rennke [121] have failed to find an increase in dry
weight despite an increase in GFR. Finally, in insulin-depen-
dent diabetes mellitus 20—40% of patients have an early eleva-
tion of glomerular filtration rate [122, 123]. In man and animals
with experimental diabetes this is associated with an increase in
kidney size [124—128]. Reduction of glomerular filtration rate by
early insulin treatment leads to a fall in GFR as well as to
normalization of kidney volume [124, 129]; later onset of
therapy may not reverse the hypertrophy [130]. In fact if kidney
size is not increased it is unlikely that there is glomerular
hyperfiltration [129].
Renotropic factors
The fact the response to a reduction in renal mass is organ-
specific and does not affect other tissues has led to a prolonged
and, thus far, unsuccessful search for a specific renal growth
factor.
Braun Menendez was the first to propose the existence of a
renal growth factor which he called "renotropin" [131]. The
first experiment suggesting the existence of such a factor was
performed by Sacerdotti who found that blood from unilaterally
nephrectomized dogs induced kidney growth when into normal
dogs [74]. Numerous studies have been subsequently per-
formed and the results of this body of investigation summarized
by Austin, Goldin and Preuss [132]. The approaches used have
included parabiosis experiments, injections of plasma and sera
(or extracts thereof) from nephrectomized animals into normal
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animals and in vitro studies in which plasma or sera have been
tested as mitogenic agents.
Parabiotic experiments have yielded conflicting results, with
most studies reporting increases in kidney weight, thymidine
incorporation into DNA, RNA and protein content. The pre-
dominance of studies reporting positive results [127—1331 is not
surprising since it is not usual for "negative" experiments to
remain relegated to the bottom drawers of investigators. Nev-
ertheless, in the 1960's a number of investigators reported
failure to find an effect of cross circulation [139—142]. Certain of
the "positive" experiments were used to distinguish the effects
of reduction of renal mass (nephrectomy) from those of loss of
renal function with normal renal mass (ureteral ligation); Malt
and Obertop [137] concluded that the former situation alone
induced hypertrophy.
Injections of sera from uni— and bilaterally nephrectomized
rats have either been found to stimulate isotopic thymidine
incorporation into DNA [143—145] or to be completely negative
in this regard [146—148].
In vitro assays should have provided the best chance of
proving or disproving the existence of a renotropin, but again
the results have been conflicting. Ogawa and Nowinski [149]
were able to demonstrate an increase in the mitotic index in
renal medullary cells in culture, which was organ specific,
following exposure of renal cells to serum obtained 2 and 15
days after nephrectomy. Preuss and colleagues [150—154] dem-
onstrated a similar effect using plasma from rats and hamsters
24 hours after nephrectomy. The putative renotropin was
considered to be organ specific and had an effect which was
additive with tissue factors in stimulating DNA and RNA
synthesis. Cortes et al [155] failed to demonstrate the existence
of a humoral factor, but the high concentration of serum (50%)
used in the assay undoubtedly exerted an inhibitory effect in
their assay system. Castillo et al [1561 and Dicker and Norris
[157] were able to confirm the results of Preuss and colleagues,
finding that the effect was specific for the renal cortex and was
only present during the first few days following uninephrecto-
my. These studies and those of Preuss et al [150] failed to
demonstrate an effect of serum from bilaterally nephrectomized
animals, suggesting that either the growth factor is released by
the kidneys or is required to interact with the kidney for its
activation.
More recent investigations have focused upon the character-
ization of such a renotropic factor. Preuss and colleagues
reported that a serum-derived stimulator or renal DNA synthe-
sis from rats was unaffected by dialysis, removal of albumin or
boiling [158]. Harris et al reinfused half of the urine output to
decrease excretory function and found that this manuever
increased DNA content, DNA synthesis, and choline incorpo-
ration into phospholipid of renal cortical tissue, compared to
the effect of a saline infusion [159]. The renotropic activity was
unaffected by heating, was greater than 10,000 daltons in size
and was unaffected by removal of one kidney, suggesting that it
was not of renal origin [159]. Yamamoto et al were able to show
stimulation of 3H-thymidine incorporation into DNA by addi-
tion of pre— and post—nephrectomy rabbit serum to a primary
culture of rabbit renal cells, and demonstrated an increase in
mitogenic activity, which was maximal at 3 to 7 days, and which
declined to pre-nephrectomy levels at 10 days [160]. The effect
was specific for renal cells and was species specific. Similar
results were obtained with human serum tested on a primary
human kidney culture. In none of the above studies were
attempts made to purify the putative growth factor.
Nomura et al have reported partial purification and charac-
terization of a renotropic fraction from ovine pituitaries [161].
This factor was capable of restoring kidney weights of
hypophysectomized, castrated rats to normal values. The pitu-
itary derived fraction was devoid of other known pituitary
hormone activity (e.g., soniatotropin, vasopressin, prolactin
corticotopin, etc.), had an isoelectric pH between 8 to 9, and
exhibited two major and one minor band on polyacrilamide gel
electrophoresis with mobilities corresponding to lutropin. Since
large amounts of standard lutropin also exhibited renotropic
action in their assay system, the putative pituitary renotropin
probably corresponded to a small population of LH or LH-like
molecules. Further studies on the nature of this factor have not
been reported.
Viewed in the context of a body of investigation which has
proceeded over a long period of time and has yielded conflicting
results on assay systems which have been far from ideal, it is
reasonable to view the existence of a specific renotropic factor
or factors with caution. It will be pointed out below that an
equally feasible explanation for the organ specificity of renal
hypertrophy can be based upon an increase in tissue sensitivity
to normally circulating growth factors which is induced by local
events within the surviving kidney tissue.
Modification of the hypertrophic response
Age
Several factors are known to modify the hypertrophic re-
sponse of the kidney to a reduction in renal mass. The most
important of these is age. In adult animals no increase in
nephron number has been observed in the hypertrophied kid-
ney. Although it has been reported that glomerular number
increases in neonatal animals [162] subsequent studies using
improved methods for glomerular counting showed no evidence
for new nephron formation, even in meaning animals [52]. As
pointed out earlier, the pattern of kidney growth differs between
young and adult animals, with hyperplasia predominating in the
former [45—53] and hypertrophy in the latter. It is generally held
that the extent of hypertrophy decreases with increasing age
[163]. This has been observed both in man and in experimental
animals.
Diet
The relationship of protein intake to hypertrophy has been
alluded to above [75—83]. High protein intake induces renal
growth in the absence of a reduction in renal mass, and
exaggerates the hypertrophic response to reduction of renal
mass. Of interest are recent reports indicating that protein
loading in rats is associated with an increase in the thickness of
the inner stripe of the outer medulla [164], reflecting
hypertrophy of the thick ascending limbs of Henle's loop and,
conversely, that protein restriction leads to a decrease in the
diameter and cell size of the thin descending limbs [165]. Both
morphological changes correlated with alterations in urine
concentrating ability.
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Hormones
Deficiencies of specific hormones have been associated with
impairment of the renal hypertrophic response. The most
important of these is hypothyroidism [166, 167]. Although it is
reasonable to suppose that kidney epithelial cells have a re-
quirement for thyroid hormone as a growth factor, it is also
important to note that the hypothyroid state is associated with
a reduction of single nephron GFR [168] and proximal tubular
reabsorption of Na [169]. If, as pointed out above, glomerular
filtration rate is a key determinant of the hypertonic response, it
is possible that the effect of thyroid hormone on kidney growth
is mediated by this mechanism.
Hypophysectomy has long been known to impair kidney
growth [170] but the specific hormone responsible for mainte-
nance of normal kidney weight has not been determined, and
combinations of growth hormone and ACTH are not able to
stimulate renal growth [171]. The existence of a specific
renotropic hormone elaborated by the pituitary has been sug-
gested [161]. In certain cases ACTH has been shown to enhance
the rate of hypertrophy [172] but this may be mediated by an
increase in testosterone levels. Although androgens lead to an
increase in kidney size and amino acid incorporation,
exogenous testosterone only enhances renal hypertrophy in
female animals [173].
Additional factors which have been shown to induce
hypertrophy in experimental animals include folic acid and
ammonium chloride (but not NaCl) loading. Folic acid increases
both RNA and DNA content of the kidney as well as the mitotic
index, indicating that it increases proliferative activity in the
kidney [174]. Ammonium chloride appears to act more selec-
tively as a hypertrophic stimulus in that RNA and protein
content of the kidney is increased without an increase in cell
number [57]. Since ammonium citrate does not have a similar
effect, it is tempting to relate the hypertrophy to the metabolic
acidosis induced by NH4C1. This is discussed below in relation
to ion fluxes.
Control of kidney cell growth in culture:
insights from in vitro studies
Growth of renal cells in defined media
The development of cell lines derived from renal tubular
epithelial cells and of primary cultures of renal epithelia have
allowed the effects of a variety of hormones and growth factors
to be tested for mitogenic activity in vitro. There is overwhelm-
ing evidence that renal epithelia derived from various segments
of the nephrons have receptors for a wide variety of growth
factors [175]. Even if there is a kidney-specific growth factor, it
is evident that, in vivo, the kidney would be subject to the
influences of a vast array of circulating factors, including
epidermal growth factor, insulin, hydrocortisone, PGE2, and
vasopressin, all of which have been shown to be mitogenic in
vitro [175, 176]. Of importance is the general observation that
two or more growth factors are required to act in concert in
order to stimulate cell proliferation, single factors having no
effect in this regard.
The renal tubular epithelium in vivo is a confluent monolayer
of quiescent cells with a very low turnover rate [177]. Growth-
inhibited, confluent cultures deprived of specific growth factors
for 24 to 48 hours in vitro closely simulate this situation, and
may remain arrested in G1/G0 for many days if the appropriate
nutrients are replenished. Addition of a combination of at least
two growth factors or a single growth factor added to a low
concentration of serum will lead to initiation of DNA synthesis
after the appropriate lag period. In vitro studies which have
defined the growth factors that allow primary cultures of renal
epithelial cells to be established and proliferate have provided
new insights into the growth requirements of these cells [178].
Taub and Sato defined a hormone-supplemented medium
which sustained the growth of a primary culture of baby mouse
kidney epithelial cells. This medium contained insulin, transfer-
rin PGE1, T3 and hydrocortisone [178]. Canine kidney cells
have been grown in a similar medium which also contained
selenium [179]. Isolated rabbit proximal tubules and the
LLCPK1 cell line, which shares many of the properties of the
proximal tubule, have been grown in a similar medium to which
vasopressin and cholesterol were added, but this medium is not
selective for the proximal tubule to also sustain the growth of
collecting tubules [180]. Primary cultures of rabbit proximal
tubules can, however, be established in a more simplified
medium containing only insulin, transferrin, and hydrocorti-
sone [181, 182]. Human kidney primary cultures have also been
established in a similar medium containing additional selenium
and epidermal growth factor [183]. (It should be pointed out that
insulin is always required in micromolar concentrations, indi-
cating that it probably does not act as a growth factor at
physiological concentrations and probably acts through insulin-
like growth factor— or somatomedin receptors). Cortical thick
ascending limbs of the rabbit require dexamethasone, thyrox-
ine, insulin, EGF and prolactin for optimal growth, whereas
cortical collecting tubules grow optimally in dexamethasone
alone [184].
Two important points emerge from studies such as these.
First, there appears to be no single growth factor or combina-
tion of factors which is selective for a particular cell type, and
second, that renal epithelia possess receptors for a variety of
circulating hormones which can act as growth factors. This
being the case, when renal growth is initiated in vivo, it appears
far more likely that the process is initiated by alteration in the
sensitivity of the cells to a permissive balance of circulating
growth factors rather than a single renal-specific factor acting as
a primary stimulus.
All of the in vitro studies cited above have utilized hormones
and growth factors as mitogenic agents which cause
hyperplasia. We have recently shown that it is possible to
create hypertrophy and not hyperplasia in vitro by utilizing
single factors rather than combinations of factors. Thus insulin,
PGE1, hypertonic NaC1 [185], each added singly to a serum-free
medium, leads to an increase in protein/cell and cell volume
without stimulating DNA synthesis. Furthermore, these
hypertrophied cells appear to remain quiescent in that the lag
period required for initiation of DNA synthesis by a mitogenic
stimulus (e.g. insulin with hydrocortisone) is identical to that
required by confluent, growth-arrested control cells. The early
events which are associated with this hypertrophy in vitro are
discussed below.
Growth inhibitors
Renal epithelial cells are confluent and quiescent and do not
undergo replication unless special circumstances prevail, e.g.,
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reduction of renal mass, hypertrophy, acute tubular necrosis,
etc. A comparable situation can be attained in vitro. When
proliferating cells reach confluence they become growth ar-
rested according to density-dependent regulatory processes.
Fibroblasts, such as 3T3 cells, are restricted primarily due to
depletion of growth factors [175]; when these are present in
overabundance, cell density can increase tenfold above that
obtained under "standard" culture conditions. In contrast,
BSC1 epithelial cells, derived from the African Green monkey
kidney, require a 20—fold increase in serum concentration to
double the cell density [175]. Crowding of these cells appears to
lead to a decrease in the number of EGF receptors [186] and an
increase in the sensitivity of the cells to small changes in the
levels of nutrients commonly present in the culture medium
[187]. Holley has suggested that growth control may be medi-
ated by a decrease in cell surface area [176]. This would
decrease the number of growth factor receptor sites and the
number of transporters, and nutrient uptake mechanisms. In-
deed, Erlinger and Saier have demonstrated a decrease in
protein content and cell volume of MDCK (canine kidney)
epithelial cells as cell density increases [188].
Of possible importance to the understanding of hypertrophy
is the role of endogenous growth inhibitors produced by the
cells [189]. BSC1 cells produce one or more high molecular
weight inhibitors which reversibly arrest the growth of BSC1
cells in the U1 phase at tg/ml concentrations [190]. Although
two inhibitory fractions have been isolated by gel filtration, high
performance liquid chromatography of each fraction yielded an
identical growth-inhibitory peak (Mr 24000), suggesting that
they may be structurally related. The mechanism of growth
arrest by such an inhibitor is not clear, The BSC1 growth
inhibitor has been shown to induce BSC1 cells to synthesize and
secrete a 48000 Mr glycoprotein within 4 to 6 hours; RNA
synthesis is required for the induction of this protein [191]. It is
thus possible that a "cascade" of two or more proteins is
required to exhibit the inhibitory effect. Another possible
mechanism of inhibition is the reduction of Na uptake by the
cell since the effect of the inhibitor could be reversed by
addition of NaC1 to the medium [192].
An exciting insight into the nature of the BSC1 growth
inhibitor has recently been provided by Tucker et al who
demonstrated that this molecule and the transforming growth
factor /3 (TGF/3) have nearly identical biological activities and
compete for binding to the same cell membrane receptor [193].
These findings indicate that the growth inhibitor and TGF/3 are
similar molecules which can either stimulate or inhibit cell
proliferation depending on the experimental conditions. The
fact that TGF/3 has been isolated from human placenta, human
platelets and bovine kidney [193], indicates that it is produced
by normal cells and may play a physiological role in the
regulation of cell growth or cell size. We have recently found
that the BSC1 inhibitor may play a role in hypertrophy [194].
When a primary culture of quiescent proximal tubular cells was
exposed to the mitogenic combination of insulin and
hydrocortisone, together with the growth inhibitor, DNA syn-
thesis was inhibited but cell protein content increased. Thus, it
appears that the inhibitor can convert a mitogenic into a
hypertrophic stimulus. This would provide an autocrine control
system for the renal epithelial cell to control its size when
stimulated by a combination of growth factors, and suggests
that cell size and DNA synthesis can be independently regu-
lated. This is discussed more fully below.
Hypertrophy and the Cell Cycle
The cell is generally conceived of as going through a cycle
which involves a period of growth in size followed by DNA
replication and mitosis. The renal tubular epithelial cell would
be classified as a "reverting postmitotic" cell in that it normally
does not synthesize DNA but can be stimulated to do so by
applying an appropriate mitogenic stimulus [177]. This quies-
cent state is referred to as G0 or the prereplicative phase. In
cells destined to undergo mitosis due to the application of a
mitogenic stimulus, gene activation leads to an early and
progressive increase in RNA and protein synthesis which is
called the U phase. This is followed by the S phase of DNA
synthesis which, in turn, is followed by a 62 phase which ends
in mitosis. The scheme, although convenient to describe the
activity of dividing cells in culture, may be oversimplistic;
indeed it may be more appropriate to consider the cell cycle as
being composed of two interacting cycles, i.e., a growth cycle
and a chromosome cycle [195]. Baserga has summarized the
evidence which clearly suggests that there are two signals for
cell growth, one to double cell size and one to replicate DNA
[196].
This latter approach seems to be more convenient for under-
standing the biology of hypertrophy, where growth is clearly
dissociated from DNA synthesis and cell proliferation. The
question becomes: Why does the growth cycle not lead to
initiation of the DNA synthetic cycle? Or alternately: Is there a
specific point in the "conventional" cell cycle at which the cell
may become arrested? There are no data on kidney epithelial
cells in this regard, but observations in other cell systems throw
interesting light on the subject. The myocardial cell is similar to
the kidney cell in that it increases its ability to perform work by
a process of hypertrophy. Sandritter and Scomazoni showed
that the DNA content of hypertrophied myocardial cells was
higher than that of normal cells [197]. Furthermore 95% of the
cell nuclei were tetraploid (four times the amount of DNA); in
severe hypertrophy octoploid nuclei were observed. If data
such as these are extrapolated to the hypertrophied kidney,
they may explain some of the findings outlined above. It has
always been assumed that the small but definite increase in
DNA content of the hypertrophied kidney is due to hyperplasia.
An alternate explanation is that nuclear polyploidy occurs in a
small proportion of cells, accounting for the small increase in
DNA content of the hypertrophied adult kidney.
A situation such as that just described requires the cells to be
arrested at S/U2 boundary, i.e., that the hypertrophied cell is a
Grblocked cell (198). Whether renal epithelial cells fit this
pattern is not clear. Furthermore, if arrest in 62 and mitosis
(which occur later than the S/G2 boundary) are excluded from
this process, it is evident that the signal for arrest of the
enlarged cell must occur in the U0, UI or S phase. It is of
interest that U2 arrested cells can be stimulated to undergo
mitosis by addition of cortisone [199] and, as pointed out above,
hydrocortisone is one of the factors which is used to promote
renal epithelial growth in vitro, and in its absence, hypertrophy
rather than hyperplasia occurs if another growth factor is
present [185].
An equally feasible alternative is that hypertrophied cells are
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arrested in G1. Prescott holds that if the growth cycle and the
chromosome cycle keep pace with each other there should be
no G1 period, i.e., the two cycles would overlap completely
[2001. If interruption occurs between mitosis and the next cycle
of DNA replication a G1 period is created. Thus, in vivo the
length of the G1 period is not determined by the rate of growth
in cell size, but by the factors which act to switch on DNA
synthesis (i.e., which initiate the S phase) [200, 201]. According
to this approach, hypertrophy could be achieved by allowing
the growth cycle to proceed while at the same time delaying or
deleting the "switch" at the start of the S phase. Although the
achievement of a given cell mass has been found to be critical
for the initiation DNA synthesis in certain cell types [2021, this
is by no means always the case [2031, and the hypertrophied cell
itself is a clear example of the fact that cell size or protein
content alone is not an adequate trigger for mitosis.
Role of ion fluxes in renal hypertrophy
The information gathered from in vitro studies has suggested
an important role of ion fluxes, specifically those of Na, H,
K and Ca , in the initiation of cell growth. Importantly, it
should be appreciated that although alterations in the transport
of these ions has been associated with mitogenesis in a variety
of cell types, the causal relationship between the transport
event and cell growth remains uncertain. At this point it appears
prudent to regard such phenomena as being associated, rather
than inducing, events in cell growth.
Na-H exchange. Of the numerous transport events which
occur at the level of proximal tubular microvillus membrane,
only Na-H antiport appears to be consistently increased by a
reduction in renal mass. This has been described in the dog
[204], the rat [205] and the rabbit [2061. The Ymax of this
transport process is increased, suggesting either an increased
number of transporter per unit of membrane or an increased
turnover number of individual transporters. The increase in
NatH antiport activity is maximal under conditions of a
transmembrane pH gradient [206] and is further increased by
increasing the protein content of the diet [2051, there being a
close positive correlation between antiport activity, kidney
weight and GFR. It appears, therefore, that the link between
SNGFR and proximal tubular reabsorption, described earlier,
may indeed be more accurately viewed as a link between
SNGFR and Na/H antiport in this nephron segment [205].
The increased influx of Na into the cell may ultimately be
responsible for the increased basolateral Na-K pump (Na-
H ATPase) activity observed in the hypertrophied kidney [58].
A large body of literature has accumulated which suggests a link
between stimulation of growth and stimulation of Na/H
antiport [207—2 13]. Addition of NaCl to the medium has also
been shown to regulate the growth of BSC1 kidney epithelial
cells in culture [216] as does vasopressin which is associated
with an increase in cell Na content [217]. On the other hand,
the specific role of an activated Na-H antiporter in the
initiation of cell proliferation has recently come under question.
In certain cell systems growth factor stimulated Na-H
antiport can be dissociated from mitogenesis [218]. In other
systems, inhibition of Na-H antiporter fail to inhibit block
growth-factor stimulated cell proliferation in a standard
CO2/HCO3 containing medium [219, 220]. Furthermore, mutant
cells lacking the Na/H antiporter continue to grow in a
HCO3—containing medium, with growth being pH-dependent
only in a HCO3—free medium [221]. Thus, if cell pH can be
regulated by any other means, growth may not be dependent
upon the antiporter, but a rise in intracellular pH does appear to
be a common early event in mitogenesis. These findings suggest
that stimulation of Na-H antiport may be related to aspects
of cell growth other than stimulated of DNA synthesis.
In this regard, it is of interest that increasing the NaC1
concentration of the medium has been found to decrease the
growth rate, and to increase RNA and protein content of HeLa
cells in culture, i.e., to induce hypertrophy [222]. We have
recently examined the association of cell hypertrophy and
Na/H antiport in a primary culture of proximal tubular cells
[185]. In these cells insulin plus hydrocortisone acts as a
mitogenic stimulus. On the other hand, insulin, PGE1 or
hypertonic NaCl when added alone, led to an increase in
protein content and cell volume at 24 or 48 hours without
stimulating DNA synthesis. Each growth stimulus was associ-
ated within an early increase (i.e., within 1 to 2 hours) of
Na-H antiport and ouabain-sensitive K uptake, the latter
process being secondary to Na influx. Thus it appears as if an
early event associated with the process of growth in size is an
influx of Na and (presumably) cell alkalinization. Whether
selective inhibition of Na/H antiport inhibits the hypertrophy
remains to be determined. Further evidence that Na-H
antiport stimulation may be linked to the process of cell
hypertrophy rather than to hyperplasia has been provided by
studies using the BSC1 growth inhibitor. When added to a
quiescent primary culture of rabbit proximal tubular cells,
together with the mitogenic combination of insulin and
hydrocortisone, stimulation DNA synthesis was inhibited, yet
protein per cell increased [194]. The stimulation of Na-H
antiport induced by insulin and hydrocortisone was not af-
fected by the inhibitor. Thus the association of increased
Na-H exchange and hypertrophy is maintained under these
circumstances.
While emphasis has been laid on the strong association
between increased Na-W antiport and renal hypertrophy, it
must again be stressed that no causal relationship between the
two processes has been demonstrated. Furthermore, even if the
hypertrophy was initiated by this specific membrane event, it is
by no means clear whether it is Na influx, cellular alkaliniza-
tion, secondary stimulation of a NaICa + exchange process,
or some other as yet unidentified event which mediates the
process. Establishing the nature of these links remains an
important challenge for the future.
Potassium. The association between hypertrophy and potas-
sium depletion has been alluded to above. Toback and col-
leagues have examined the effects of medium potassium con-
centration on the growth of BSC1 cells in vitro. Exposure to a
medium K concentration of 3.2 m (compared with the
normal medium concentration of 5.4 mM) increased the number
of microvilli per cell, per unit surface area, by 45% after only
three minutes [223]. This concentration of K also appears to
be quite specific for stimulation of cell proliferation in that K
concentrations lower than 3.2 do not increase the growth rate of
these cells [224]. Under these conditions, the cells release a
growth-stimulating substance into the medium within one hour
which is able to stimulate the growth of fresh cultures of cells
[225]. At least one component of this stimulatory activity has
628 Fine
Fig. 1. Sequence of events in renal tubular cell hypertrophy.
been shown to be a protein with an Mr of 62,000, which
stimulates D-glyceraldehyde-3-phosphate: NAD oxoreductase
(G3PD) [226]. The effects of the low medium Kt concentration
on both cell growth and on G3PD activity appear to be
Nat.dependent, in that lowering the Nat concentration of the
medium from 155 to 150 m abolished these effects [227]. It is
not clear whether the Nat dependence is mediated by the
NatHt antiporter in this system.
In contrast to these findings are the opposite, and apparently
conflicting, observations that decreasing extracellular Kt con-
centration inhibits DNA synthesis in 3T3 [229] and LM (TK)
fibroblasts [229]. This effect, however, is observed only at
medium concentrations below 0.4 to 0.5 m. Furthermore, in
BSC1 cells, increasing the medium Kt concentration from 5 to
20 m increases DNA synthesis in a linear fashion [231]. Thus
in the same cell type both a low Kt concentration (within a
narrow range) and a high Kt concentration appear to stimulate
cell growth. Whether cell size and morphology differ between
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these two apparently opposite conditions has not yet been
determined.
One of the important differences between the renal
hypertrophy induced by potassium depletion and that induced
by reduction of renal mass is that GFR is not elevated in the
former. Since the link between GFR and hypertrophy has been
stressed above, the Kt depletion model appears to argue
against the existence of such a link. In this regard, it is of great
interest that Seifter et al have recently reported that NatHt
exchange is increased in the proximal tubular brush border
membrane of Kt_depleted animals [231]. These findings further
support the link between this transport process and
hypertrophy.
Calcium
Evidence that serum-stimulation of fibroblast growth in cul-
ture is secondary to an elevation of intracellular calcium activ-
ity was provided by Villareal, who demonstrated that a calcium
ionophore can mimic the effects of serum in stimulating
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amiloride-sensitive Na influx [232]. Since this occurred in the
presence and absence of extracellular calcium, elevation of
cytosolic calcium originating either from intracellular or extra-
cellular sources was effective. Subsequent studies confirmed
the probable intracellular origin of the calcium [2331. Studies by
other workers confirmed this finding in other cell systems
exposed to specific growth factors [2341.
With regard to renal hypertrophy, there have been no studies
which have directly examined the effects of calcium fluxes or
intracellular free calcium on this process. Jobin et a! have
reported that calcium restriction and parathyroid hormone
enhance renal compensatory growth [238], and since parathy-
roid hormone has been shown to enhance calcium uptake into
cultured kidney cells [239], there is a possibility that elevation
of cytosolic calcium activity acts to regulate or initiate the
process of renal hypertrophy.
Overview
From the vast amount of data available it is obviously
impossible to construct a schema which describes the sequence
of events that transforms a normal renal tubular cell into an
enlarged cell with an increased transport capacity, and which is
consistent with all of the existing information in the literature.
In Figure 1, I have attempted to synthesize most of the available
information into an intelligible schema which can act as the
basis for further inquiry. The basic tenet which underlies this
approach is that renal tubular hypertrophy is not under the
control of a specific renal growth factor. Rather, a sequence of
events, usually initiated by an increase in single nephron
glomerular filtration rate (possibly under the control of circu-
lating or local hormones), increases the sensitivity of the
tubular cells to a permissive balance of circulating and local
growth factors. This may be initiated by the mechanical effect
of an increased tubular fluid flow rate, but such a mechanism
has thus far not been established. In the heart, the mechanical
effect of increased aortic pressure increases protein synthesis
within one hour [240], indicating that a precedent for mechan-
ical stimulation of cell growth does exist. A central feature of
this altered sensitivity appears to be an increase in the activity
of the Na-H antiporter, but how this transport event is related
to increased phospholipid and protein biosynthesis is unclear. It
should be stressed that there is no evidence to indicate that
increased Na-H antiport acts as a specific initiating factor for
hypertrophy and it is also uncertain whether early stimulation
of this process occurs in all forms of hypertrophy.
The increased sensitivity of the renal tubular cells to growth
factors allows these factors to act as mitogens, but, rather than
leading to cell proliferation, they induce hypertrophy owing to
the elaboration of one or more endogenous growth inhibitors
which transform the mitogenic stimulus into a hypertrophic
stimulus. An alternative possibility is that certain local factors
which do not possess mitogenic activity may lead to
hypertrophy in sensitized cells by an, as yet, undetermined
mechanism. This may be the case with angiotensin II [241].
Since an increase in dietary protein intake leads to renal
hypertrophy as well as to an increase in plasma renin activity
[2421, the role of this hormone in hypertrophy requires further
study. The result of this process is a cell which is enlarged with
an increased complement of all its normal component molecules
and organelles, and which has the capacity to perform a greater
amount of reabsorptive and secretory work.
LEON FINE
UCLA School of Medicine
Los Angeles, California, USA
Notes added in proof
Structural considerations. It has been recently been reported
that vasopressin administration to Brattleboro rats with con-
genital diabetes insipidus leads to selective hypertrophy of the
medullary thick ascending limb. (BOUBY N, BANKIR L,
TRINH—TRANG—TAN MN, MINUTH WW, KRIz W: Selective
ADH—induced hypertrophy of the medullary thick ascending
limb in Brattleboro rats. Kidney mt 28:456—466, 1985). A similar
effect was observed in response to a high protein diet in normal
rats, a maneuver which also augments the urinary concentrating
mechanism [164].
Hypertrophy and the cell cycle. The majority of cells in the
hypertrophied kidney appear to be arrested in G0/G1. (L. G.
Fine, unpublished observations).
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